Vor Biopharma (VOR) Current Assets (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Current Assets data on file, last reported at $500.8 million in Q1 2026.

• Current Assets for Q1 2026 came in at $500.8 million, up 672.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $500.8 million (up 672.25% YoY), and the FY2025 annual result was $458.1 million, up 374.69% from the prior year.
• Current Assets improved to $500.8 million in Q1 2026 per VOR's latest filing, from $458.1 million in the prior quarter.
• Over five years, Current Assets peaked at $500.8 million in Q1 2026 and troughed at $64.8 million in Q1 2025.
• A 5-year average of $188.8 million and a median of $164.4 million in 2023 frame the typical range for Current Assets.
• The sharpest annual moves came in 2024 and 2026: Current Assets sank 59.08% in 2024, then soared 672.25% in 2026.
• A 5-year view of Current Assets shows it stood at $237.0 million in 2022, then tumbled by 40.58% to $140.8 million in 2023, then tumbled by 31.46% to $96.5 million in 2024, then soared by 374.69% to $458.1 million in 2025, then increased by 9.32% to $500.8 million in 2026.
• Business Quant data shows VOR's Current Assets at $500.8 million in Q1 2026, $458.1 million in Q4 2025, and $172.5 million in Q3 2025.